Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

Completed · Phase 2

Conditions studied: Open-Angle Glaucoma, Ocular Hypertension

In brief

To determine the safety and IOP-lowering ability of a test compound in patients with open-angle glaucoma or ocular hypertension.

Key facts

Study ID

NCT00069719

Run by

Alcon Research

Starts

1999-02-01

Expected to finish

2003-08-01

Last updated by the study team

2008-08-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension;
• logMAR visual acuity not worse than 0.6.

You may not qualify if…

• Clinically relevant ophthalmic or systemic conditions may be excluded.

Where it is running

• Alcon Clinical Trial Sites — Multiple Locations Throughout the US Sponsored by Alcon of, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.